Antares Pharma, Inc.
(NASDAQ : ATRS)

( )
ATRS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp. -1.53%321.510.7%$882.54m
TMOThermo Fisher Scientific, Inc. -2.41%633.151.0%$857.83m
ABTAbbott Laboratories -1.89%125.610.8%$662.68m
MDTMedtronic Plc -3.24%106.710.6%$623.96m
ISRGIntuitive Surgical, Inc. -3.11%324.340.8%$451.92m
DXCMDexCom, Inc. -1.48%562.597.8%$377.07m
BDXBecton, Dickinson & Co. -2.68%237.091.0%$363.70m
BSXBoston Scientific Corp. -1.63%37.961.0%$342.68m
ALGNAlign Technology, Inc. -3.62%611.536.4%$321.01m
SYKStryker Corp. -2.85%236.561.3%$305.17m
EWEdwards Lifesciences Corp. -3.13%107.240.4%$256.34m
AAgilent Technologies, Inc. -1.65%150.891.6%$245.52m
IDXXIDEXX Laboratories, Inc. -3.68%608.073.8%$230.32m
ZBHZimmer Biomet Holdings, Inc. -3.17%119.591.7%$221.27m
WSTWest Pharmaceutical Services, Inc. -1.01%442.861.6%$189.13m

Company Profile

Antares Pharma, Inc. is a combination drug device company, which engages in the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its proprietary products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ.